Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Ritlecitinib can help about 14,000 people with severe hair loss.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Setipiprant did not significantly improve hair growth in men with hair loss.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.